Dobutamine In Dextrose Injection, Solution
Product Images NDC 0409-0025
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dobutamine In Dextrose (NDC 0409-0025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula Dextrose (Dobutamine 02)
Hospira Logo (Dobutamine 03)
Hospira Logo (Dobutamine 04)
Principal Display Panel (250 mL Bag)
DOBUTamine in 5% Dextrose Injection, USP is a sterile, nonpyrogenic solution for intravenous use. Each 100 mL contains dobutamine hydrochloride equivalent to 200 mg of dobutamine along with dextrose, metabisulfite, and edetate disodium dihydrate as stabilizers. The solution has a pH of 2.5 to 5.5 and a mOsmol or molal concentration of 270. It should be stored at controlled room temperature and must not be used in 200 series connections. The usual dosage should be followed as instructed in the insert, and it contains sulfites. Any drug additives should not be added to this solution. If the solution is clear and the container is undamaged, it must only be used in usual doses.*
Principal Display Panel (250 mL Bag Overwrap)
This is a pharmaceutical product containing Dabutamine Hydrochloride in 5% Dextrose Injection, USP. It has a strength of 500 mg/250 mL and is packaged in a single-dose container. It is important to check for minute leaks in the container after removing the overwrap, as the sterility may be impaired. The solution may exhibit a pink color, but this does not affect its potency. The container should be stored at room temperature and away from freezing.*
Principal Display Panel (250 mL Bag)
This is a description of a drug called DOBUTamine which is available as an injection in 5% Dextrose solution. It comes in a strength of 250 mg/250 mL (1000 mcg/mL) and is used for intravenous administration. Each 100 mL of the solution contains Dobutamine hydrochloride equivalent to 100 mg of Dobutamine along with 5g dextrose, 25 mg sodium metabisulphite, and 10 mg edetate disodium dihydrate as stabilizers. The pH of the solution is 3.0 (2.5 to 5.5) and it has an osmolarity of 263 mOsmol/L. The drug should not be used with sulfites and should not be mixed with any other drug additives. The drug is sterile, nonpyrogenic and should be used only if the solution is clear and the container is undamaged. Storage instructions are also mentioned.*
Principal Display Panel (250 mL Bag Overwrap)
This is a description of a medication called Dobutamine in 5% Dextrose Injection, USP. It is contained in a 250mL single-dose container with a tear notch. Each 100mL of the solution contains 100mg of Dobutamine Hydrochloride along with dextrose hydrous (5g with sodium metabisulfite 25mg), and other stabilizers. The medication is meant for intravenous use and may include hydrochloric acid and/or sodium hydroxide for pH adjustment. The medicine is stored at 20 to 25°C and should be protected from freezing. The overwrap is a moisture and oxygen barrier, and the medicine should not be used if the overwrap is damaged. The solution may exhibit a pink color, but significant loss of potency has not occurred even if discolored. The container should be inspected for leaks before use, and the solution should be discarded if there are any leaks as safety may be compromised. The medication is distributed by Hospira Inc, Lake Forest, IL, USA.*
Principal Display Panel (250 mL Bag)
This is a medication called Dobutamine which is combined with 5% dextrose for injection. Each 100ml contains Dobutamine Hydrochloride equivalent to 400mg of Dobutamine, dextrose hydrous 5g, sodium metabisulfite 25mg, and edetate disodium dihydrate 10mg added as stabilizers. It may contain Hydrochloric acid and/or sodium hydroxide for pH adjustment, and it's intended for intravenous use. The solution must be clear, and the container must be undamaged. The medication is distributed by Hospira, Inc. in the USA. The dosage details are not available.*
Principal Display Panel (250 mL Bag Overwrap)
Product Name: Unknown
Active Ingredient: Dabutamine Hydrochloride
Dosage Strength: 1,000 mg/250 mL
Dosage Form: Injection
Indication: The injection is for intravenous use and is infused to increase cardiac output in patients with heart failure
Special Instructions: Do not add any drug additives to the solution. Discard the solution if there are any tears or holes in the overwrap as it may lead to contamination. The solution may display a pink color, but it is safe to use as long as there is no significant loss of potency. Check the container for any leaks before use.
Storage: Store at 20°C to 25°C (68°F to 77°F). Protect from light.
Warning: Contains sulfites.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.